Amdocs stock
DOXNASDAQAmdocs Limited, TechnologyISIN GB0022569080
59Score 59 out of 100, Neutral
Price and trend
24 / 100
Price history
−43% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 28% below it.
Since September 2025 the 50-day line has been below the 200-day line; the trend has turned down.
Sharply down: the price has fallen very quickly lately (RSI 17).
The price is 48% below its 52-week high. Largest decline in 20 years: 60% (July 2007 to March 2009).
Chart figures for advanced users
- SMA 50$57.88
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$61.00
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)17
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$41.46
- The lowest closing price of the last twelve months.
- Resistance$84.29
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Amdocs Limited belongs to the Software (Infrastructure) industry (United States) and, with a market value of $4.74B, is number 53 of 97 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $4.7B (up 3.6% year on year) and earnings of $501.24M (down 11.2%).
- For fiscal 2027, analysts expect on average revenue of $3.94B (down 16%) and adjusted earnings per share of $5.47 (down 26.2%).
Show more
- MEQIRI Score 59 out of 100 (Neutral): rank 460 of 857 in Technology, median 61.
- The P/E is 9.2 (Software (Infrastructure) median 26.3, own median of recent years 18.2).
- Our model puts fair value at $110.37, with the price 61% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Modestly valuedP/E 9.2, Software (Infrastructure) median 26.3, own median 18.2.Valuation 91
- Share buybacksShare count down 17% since 2021.Capital allocation 87
- High dividend yieldDividend yield 5.18%, Software (Infrastructure) median 1.41%.Capital allocation 87
Weaknesses
- Share price fell sharplyDown 47% over the last 12 months.Momentum 12
- Analysts expect falling earningsDown 5.1% a year through 2028 (estimates from 3 analysts).Growth 26
Its standout strengths are fundamentals and valuation, while technical analysis and momentum hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- price far below its 52-week high
- high price swings
- weak momentum
What lowers it
- solid fundamentals
- price not overheated over the past year
Valuation
Valuation signal
Possible value trapClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $78.83 and expensive above $183.95 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $94.19 (cash-flow model) and $126.55 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 10.1%. At 11.1% the fair value would be $103.80, at 9.1% it would be $119.41.
Possible value trap: looks cheap, but weak growth.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (26.3).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2026, revenue rose 3.6% on the prior year. Revenue has stayed largely stable since 2007.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 36%, operating 18%, net 11%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with moderate debt and comfortable interest coverage.
Earnings
- Next earnings
- 2 Feb 2027in 82 days
- Last reported
- 3 Nov 2026EPS reported $1.98 (expected $1.98)in line with expectations
Analyst estimates
Analysts have cut their 2028 earnings estimate by 33.4% since 15 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- $5.47−31.8%
- Revenue
- $3.94B−18.6%
- Earnings per share
- $6.12−33.4%
- Revenue
- $4.08B−18.6%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +4.2%Midpoint of the fiscal 2026 outlook reiterated (revenue up 3% in constant currency, non-GAAP EPS up 6%), ranges tightened.
“On a constant currency basis, we expect revenue growth within a tighter range of between 2.6% and 3.4% for the full fiscal year, the 3% midpoint of which is also unchanged as compared with our previous guidance. As to the fourth fiscal quarter, we expect revenue of between $1.175 billion to $1.215 billion.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 5 Aug 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
3 insiders bought on the open market between 9 Nov 2026 and 10 Nov 2026, $82,292 in total. One insider sold, $29,005 in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
Not counted: 2 purchases under a fixed plan (compensation, savings plan or a pre-arranged Rule 10b5-1 trading plan).
- MacDonald John AnthonyPurchase
10 Nov 2026, Board
- Shares
- 1,000
- Price
- $41.63
- Value
- $41,630
- Morali VeroniquePurchase
10 Nov 2026, Board
- Shares
- 134
- Price
- $41.31
- Value
- $5,536
- Kanouff YvettePlan purchase
9 Nov 2026, Board
- Shares
- 2,400
- Price
- $42.00
- Value
- $100,800
Show 3 more
- Genish AmosPlan purchase
9 Nov 2026, Board
- Shares
- 3,565
- Price
- $42.00
- Value
- $149,730
- Davis Sarah R.Purchase
9 Nov 2026, Board
- Shares
- 822
- Price
- $42.73
- Value
- $35,127
- Smith Matthew E.Sale
29 May 2026, See Remarks
- Shares
- 464
- Price
- $62.51
- Value
- $29,005
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Amdocs
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
857 rated companies in Technology
- This company
- 59
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Software (Infrastructure)
The next larger and next smaller companies by market value
- BlackBerryBB $5.52B59
- Trend Micro4704.T $5.48B75
- Remitly GlobalRELY $4.89B71
- Core ScientificCORZ $4.69B33
- Tenable HoldingsTENB $4.49B57
- Shift4 PaymentsFOUR $4.3B51
- Paymentus HoldingsPAY $4.29B74
- DlocalDLO $4.11B80
ETFs that hold Amdocs
Held by 5 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares Smart City Infrastructure UCITS ETFAYEU | 0.70% | 0.40% | €343.1M |
| Invesco RAFI US Fundamental Value UCITS ETF6PSA | 0.03% | 0.39% | €1.23B |
| Invesco RAFI All-World Fundamental Value UCITS ETFPSWD | 0.02% | 0.39% | €446.84M |
Show 2 more
| Vanguard ESG Global All Cap UCITS ETF (USD) AccumulatingV3AA | 0.01% | 0.24% | €1.69B |
| Vanguard FTSE Global All-Cap UCITS ETF Accum USDVGLA | 0.00% | 0.07% | €3.9B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Sep 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 24 Apr 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.